Medistim ASAFRA:MD1 -1.49%100 EV-to-FCF is 22.74 as of Jul. 05, 2026, which is 31% below its 10-year median of 32.77. GuruFocus rates FRA:MD1 with a GF Score™ of 100/100 and a GF Value™ of €22.61 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 417 Medical Devices & Instruments companies, Medistim ASA ranks better than 53% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medistim ASA's Enterprise Value is €349.97 Mil.
Medistim ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €15.39 Mil. Therefore, Medistim ASA's EV-to-FCF for today is 22.74.
The historical rank and industry rank for Medistim ASA's EV-to-FCF or its related term are showing as below:
FRA:MD1'
s EV-to-FCF Range Over the Past 10 Years
Min: 16.4 Med: 32.77 Max: 94.76
Current: 22.19
During the past 13 years, the highest EV-to-FCF of Medistim ASA was 94.76. The lowest was 16.40. And the median was 32.77.
FRA:MD1's EV-to-FCF is ranked better than 53% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.4
vs FRA:MD1: 22.19
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medistim ASA's PE Ratio (TTM) for today is calculated as:
Medistim ASA's share price for today is €19.90.
Medistim ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.739.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medistim ASA EV-to-FCF Related Terms
Medistim ASA EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Medistim ASA's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medistim ASA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistim ASA EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medistim ASA's EV-to-FCF falls into.
Medistim ASA's current Enterprise Value is €349.97 Mil.
Medistim ASA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistim ASA (FRA:MD1) has a EV-to-FCF of 22.74 as of Jul. 05, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medistim ASA and its competitors. This is 31% below median its historical median of 32.77. Over the past decade, Medistim ASA's EV-to-FCF has ranged from 16.40 to 94.76. According to the industry distribution chart, Medistim ASA ranks #196 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 47%.
Is Medistim ASA's EV-to-FCF too high?
Medistim ASA's current EV-to-FCF of 22.74 is 31% below median its 10-year median of 32.77. Over the past 10 years, this metric has ranged from a low of 16.40 to a high of 94.76. The Medical Devices & Instruments industry median EV-to-FCF is 23.40. Medistim ASA's value of 22.74 is 2.8% below this industry median. Based on the distribution chart, Medistim ASA ranks #196 out of 417 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medistim ASA has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medistim ASA ranks #196 out of 417 companies for EV-to-FCF. This puts Medistim ASA in the upper half of its industry. The industry median EV-to-FCF is 23.40. Medistim ASA's value of 22.74 is 2.8% below this benchmark. Historically, Medistim ASA's own EV-to-FCF has ranged from 16.40 to 94.76 over the past decade. While the company's 10-year median is 32.77 vs. the industry median of 23.40, Medistim ASA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.40, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistim ASA's current EV-to-FCF of 22.74 is 2.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medistim ASA and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistim ASA's current EV-to-FCF is 22.74, which is 31% below median its own 10-year median of 32.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Based on GuruFocus' analysis, Medistim ASA (FRA:MD1) is currently considered Modestly Undervalued. The stock's GF Value™ is €22.61, compared to a current price of €19.90 — trading 12% below its estimated fair value. The current EV-to-FCF is 22.74, which is 31% below median its 10-year median of 32.77 and 2.8% below the Medical Devices & Instruments industry median of 23.40. Medistim ASA's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medistim ASA (FRA:MD1), the current EV-to-FCF is 22.74 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medistim ASA (FRA:MD1) Overvalued in 2026?
Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued.
The current stock price of €19.90 is trading 12% below its estimated GF Value™ of €22.61.
GuruFocus considers Medistim ASA to be Modestly Undervalued.
Key valuation signals for FRA:MD1:
EV-to-FCF: 22.74 (31% below median its 10-year median of 32.77)
GF Value™: €22.61 vs. price of €19.90 (12% below fair value)
Industry Position: 2.8% below the Medical Devices & Instruments median (#196 of 417)
No single metric tells the full story. See the FRA:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
100GF Score
Get the complete analysis for FRA:MD1
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MD1 has been successfully added to your 
